Boris Zaïtra (pictured), currently head of group business development, will be appointed as head of corporate business development, effective 1 july 2024. James Sabry, head of Roche Pharma Partnering, will be retiring after fourteen years in the company. Boris Zaïtra’s appointment Zaïtra’s new role will bring together the Pharma Partnering and Group business development functions. […]
Bär & Karrer and Willkie Farr & Gallagher advised PAI Partners (PAI) on the acquisition of Vamed Group’s rehabilitation business (VAMED) from Fresenius, advised by NKF and Latham & Watkins. PAI will become
According to his LinkedIn profile, Martin Oesch (pictured) is starting a new position as senior vice president, general counsel & chief compliance officer, and member of the Executive Committee of SGS. Oesch’s career path
Novartis AG, the Swiss multinational pharmaceutical corporation based in Basel, has appointed Alejandro Bes (pictured) as its global head of legal for the Immunology business unit. The lawyer steps into the role as his predecessor,
